公开(公告)号：US20220168366A1

公开(公告)日：2022-06-02

申请号：US17434990

申请日：2020-03-02

Applicant: GlaxoSmithKline Biologicals SA ,  Washington University

Inventor： Michael J. BARRATT ,  Nicolas Frederic DELAHAYE ,  Jeffrey I. GORDON

IPC: A61K35/748 ,  A61K35/742 ,  A61K35/741 ,  A61K47/46 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/375 ,  A61K31/593 ,  A61K31/355 ,  A61K31/519 ,  A61K39/39 ,  A61K9/50 ,  A61P37/04

Abstract: A nutraceutical composition comprising prebiotics, probiotics, and/or synbiotics, spirulina, cereals and micronutrients for improving a person's health, and methods for boosting the immune system and improving vaccine effectiveness in vulnerable populations with the nutraceutical composition, including undernourished children, lactating and pregnant mothers in LDCs, the elderly, and persons with cancer or at risk of developing cancer.

公开(公告)号：US20220062409A1

公开(公告)日：2022-03-03

申请号：US17413203

申请日：2019-12-13

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Stefania CAPONE ,  Nicolas Frederic DELAHAYE ,  Giulietta MARUGGI ,  Haifeng SONG

IPC: A61K39/245 ,  A61K39/21 ,  A61K39/205 ,  A61P31/14 ,  A61P31/18 ,  A61P31/22

Abstract: Simian adenoviral vectors and RNA molecules, each encoding an immunogen of interest, can be sequentially administered to provide potent and long-lasting immunity.